Last Posted: Oct 18, 2019
- DNA Tests For Psychiatric Drugs Are Controversial But Some Insurers Are Covering Them
G Dangor, NPR, October 17, 2019 - Integrating pharmacogenomics into the electronic health record by implementing genomic indicators.
Caraballo Pedro J et al. Journal of the American Medical Informatics Association : JAMIA 2019 Oct - Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.
Zhu Ye et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Oct - A pediatric perspective on genomics and prevention in the twenty-first century.
Chaudhari Bimal P et al. Pediatric research 2019 Oct - A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
Weitzel Kristin Wiisanen et al. Pharmacogenomics 2019 Oct 20(15) 1103-1112 - Pharmacogenetics and the treatment of epilepsy: what do we know?
Božina Nada et al. Pharmacogenomics 2019 Oct 20(15) 1093-1101 - Pharmacogenomics: Prescribing Precisely.
Wake Dyson T et al. The Medical clinics of North America 2019 Nov 103(6) 977-990 - Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives.
Chumnumwat Supatat et al. Public health genomics 2019 Oct 1-8 - Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms
M Bachtiar et al, The Pharmacogenomics Journal, October 3, 2019 - Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications.
Kaliyaperumal Kalaiyarasi et al. Journal of hepatology 2018 Oct 69(4) 948-957
No hay comentarios:
Publicar un comentario